MANPREET CHAWLA: Open Payments
NPI 1710445333 · EGG HARBOR TOWNSHIP, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 18 payments from 11 companies in 2025. Trend: 2023 $101 · 2024 $548 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $55 |
| Novo Nordisk Inc | 3 | $54 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $46 |
| Astellas Pharma US Inc | 2 | $39 |
| ABBVIE INC. | 2 | $30 |
| Madrigal Pharmaceuticals | 1 | $19 |
| Radius Health, Inc. | 1 | $19 |
| Medtronic, Inc. | 1 | $18 |
| Rhythm Pharmaceuticals, Inc. | 1 | $17 |
| BETA BIONICS, INC. | 1 | $16 |
Products named: Dexcom G6 Transmitter, Ozempic, ISTURISA, Veozah, UBRELVY, REZDIFFRA, MINIMED 780G, IMCIVREE.
Industry payments across NJ — which companies pay providers there.
